Erratum: Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating mapk pathway activation (PLoS ONE (2014) 9:6 (e100893) doi:10.1371/journal.pone.0100893);Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Li, Ruiya ^a   Zhang, Lingli ^a   Jia, Lizhou ^b   Duan, Yan ^a   Li, Yan ^b   Bao, Lidao ^b   Sha, Na ^a  

^a INNER MONGOLIA PEOPLE S HOSPITAL   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; B RAF KINASE; LONG UNTRANSLATED RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RAF PROTEIN; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENICITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INACTIVATION; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SURVIVAL RATE; ADULT; AGED; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ADULT; AGED; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MELANOMA; MICE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM STAGING; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-RAF; RNA, LONG NONCODING;

EID: 84903437794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118728     Document Type: Erratum

References (36)

1. MacKie RM, Hauschild A, Eggermont AM (2009) Epidemiology of invasive cutaneous melanoma. Ann Oncol (suppl. 6):vi1-7.
2. Miller AJ, Mihm MC Jr. (2006) Melanoma. N Engl J Med 355(1):51-65.
3. Margue C, Philippidou D, Reinsbach SE, Schmitt M, Behrmann I, et al. (2013) New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion. PLoS One 8(9):e73473.
4. Lee DJ, Kang DH, Choi M, Choi YJ, Lee JY, et al. (2013) Peroxiredoxin-2 represses melanoma metastasis by increasing E-Cadherin/β-Catenin complexes in adherens junctions. Cancer Res 73(15):4744-57.
5. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, et al. (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477:295-300.
6. Cheetham SW, Gruhl F, Mattick JS, Dinger ME (2013) Long noncoding RNAs and the genetics of cancer. Br J Cancer 108(12):2419-25.
7. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361.
8. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464(7291):1071-6.
9. Yang L, Lin C, Jin C, Yang JC, Tanasa B, et al. (2013) lncRNA-dependent mechanisms of androgen- receptor-regulated gene activation programs. Nature 500(7464):598-602.
10. Yang X, Song JH, Cheng Y, Wu W, Bhagat T, et al. (2013) Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 9(2):305266.
11. Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, et al. (2012) BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res 22(6):1006-14.
12. McCarthy N (2012) Epigenetics. Going places with BANCR. Nat Rev Cancer 12(7):451.
13. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, et al. (2005) The transcriptional landscape of the mammalian genome. Science 309(5740): 1559-63.
14. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, et al. (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 308(5725):1149-54. (Pubitemid 40696429)
15. Yang Z, Zhou L,Wu LM, Lai MC, Xie HY, et al. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18(5):1243-50.
16. Jiang M, Huang O, Xie Z, Wu S, Zhang X, et al. (2013) A novel long non-coding RNA-ARA: Adriamycin Resistance Associated. Biochem Pharmacol pii: S0006-2952(13)00687-4.
17. Ellis BC, Graham LD, Molloy PL (2013) CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta pii: S0167-4889(13)00361-3.
18. Wu W, Zhang S, Li X, Xue M, Cao S, et al. (2013) Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One 8(9):e73920.
19. Hombach S, Kretz M (2013) The non-coding skin: Exploring the role of long non-coding RNAs in epidermal homeostasis and disease. Bioessays 35(12):1093-100.
20. Nagano T, Fraser P (2011) No-nonsense functions for long noncoding RNAs. Cell 145(2):178-181.
21. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26(22):3291-310. (Pubitemid 46763022)
22. Solus JF, Kraft S (2013) Ras, Raf, and MAP kinase in melanoma. Adv Anat Pathol 20(4):217-26.
23. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ (2000) Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol 10(4):147-54. (Pubitemid 30171309)
24. Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, et al. (2009) Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc Natl Acad Sci U S A 106(19):7957-61.
25. Lasithiotakis KG, Sinnberg TW, Schittek B, Flaherty KT, Kulms D, et al. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J Invest Dermatol 128(8):2013-23.
26. Ke H, Harris R, Coloff JL, Jin JY, Leshin B, et al. (2010) The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia. Cancer Res 70(8):3080-8.
27. Jin JY, Ke H, Hall RP, Zhang JY (2011) c-Jun promotes whereas JunB inhibits epidermal neoplasia. J Invest Dermatol 131(5):1149-58.
28. Ke H, Augustine CK, Gandham VD, Jin JY, Tyler DS, et al. (2013) CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways. J Invest Dermatol 133(1):221-9.
29. Shieh JM, Huang TF, Hung CF, Chou KH, Tsai YJ, et al. (2010) Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells. Br J Pharmacol 160(5):1171-84.
30. Han J, Sun P (2007) The pathways to tumor suppression via route p38. Trends Biochem Sci 32(8):364-71. (Pubitemid 47126858)
31. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, et al. (2009) Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15(4):294-303.
32. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949-54. (Pubitemid 34716871)
33. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, et al. (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418(6901):934. (Pubitemid 34976022)
34. Wang W, Wang X, Peng L, Deng Q, Liang Y, et al. (2010) CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation. Cancer Sci 101(1):112-9.
35. Marampon F, Bossi G, Ciccarelli C, Di Rocco A, Sacchi A, et al. (2009) MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Mol Cancer Ther 8(3):543-51.
36. Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, et al. (2013) Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth. Mol Imaging Biol 15(2):175-85.